| Pharmaceutical applications of cyclodextrins. 2. in vivo drug delivery RA Rajewski, VJ Stella Journal of pharmaceutical sciences 85 (11), 1142-1169, 1996 | 1234 | 1996 |
| Chemical stability of pharmaceuticals: a handbook for pharmacists KA Connors, GL Amidon, VJ Stella John Wiley & Sons, 1986 | 964 | 1986 |
| Cyclodextrins VJ Stella, Q He Toxicologic pathology 36 (1), 30-42, 2008 | 896 | 2008 |
| Pro-drugs as novel drug delivery systems T Higuchi, V Stella American Chemical Society, 1975 | 807 | 1975 |
| Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof V Stella, R Rajewski US Patent 5,134,127, 1992 | 803 | 1992 |
| Prodrug strategies to overcome poor water solubility VJ Stella, KW Nti-Addae Advanced drug delivery reviews 59 (7), 677-694, 2007 | 779 | 2007 |
| A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues J Fassberg, VJ Stella Journal of pharmaceutical sciences 81 (7), 676-684, 1992 | 586 | 1992 |
| Mechanisms of drug release from cyclodextrin complexes VJ Stella, VM Rao, EA Zannou, V Zia Advanced drug delivery reviews 36 (1), 3-16, 1999 | 553 | 1999 |
| Stability of drugs and dosage forms S Yoshioka, VJ Stella Springer Science & Business Media, 2000 | 501 | 2000 |
| Prodrugs as therapeutics VJ Stella Expert opinion on therapeutic patents 14 (3), 277-280, 2004 | 400 | 2004 |
| Prodrugs: Do they have advantages in clinical practice? VJ Stella, WNA Charman, VH Naringrekar Drugs 29, 455-473, 1985 | 366 | 1985 |
| Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof VJ Stella, AE Mathew US Patent 4,960,790, 1990 | 362 | 1990 |
| Prodrugs: challenges and rewards V Stella, R Borchardt, M Hageman, R Oliyai, H Maag, J Tilley Springer Science & Business Media, 2007 | 360 | 2007 |
| Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity AE Mathew, MR Mejillano, JP Nath, RH Himes, VJ Stella Journal of medicinal chemistry 35 (1), 145-151, 1992 | 353 | 1992 |
| Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations VJ Stella, RA Rajewski, VM Rao, JW McGinity, GL Mosher US Patent 6,046,177, 2000 | 306 | 2000 |
| Prodrugs of rapamycin VJ Stella, PE Kennedy US Patent 4,650,803, 1987 | 306 | 1987 |
| Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability MN Arimilli, KC Cundy, JP Dougherty, CU Kim, R Oliyai, VJ Stella US Patent 5,977,089, 1999 | 289 | 1999 |
| Sulfobutyl ether. beta.-cyclodextrin as a chiral discriminator for use with capillary electrophoresis RJ Tait, DO Thompson, VJ Stella, JF Stobaugh Analytical Chemistry 66 (22), 4013-4018, 1994 | 271 | 1994 |
| Methods for a particle precipitation and coating using near-critical and supercritical antisolvents B Subramaniam, S Saim, RA Rajewski, V Stella US Patent 5,833,891, 1998 | 268 | 1998 |
| Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use V Stella, RA Rajewski, JW McGinity US Patent 5,874,418, 1999 | 261 | 1999 |
